Patient Buzz: Rare Pediatric Skin Conditions | The Expert Weighs In
Parade and other media outlets recently covered the story of actress Mandy Moore's son, who was diagnosed with Gianotti-Crosti syndrome. What should dermatology clinicians know about Gianotti-Crosti syndrome and other rare pediatric skin conditions? What should dermatology clinicians do when they are unsure of how to diagnose a pediatric skin condition?
For expert advice, I reached out to …
Parade and other media outlets recently covered the story of actress Mandy Moore's son, who was diagnosed with Gianotti-Crosti syndrome. What should dermatology clinicians know about Gianotti-Crosti syndrome and other rare pediatric skin conditions? What should dermatology clinicians do when they are unsure of how to diagnose a pediatric skin condition?
For expert advice, I reached out to … Continue reading "Patient Buzz: Rare Pediatric Skin Conditions | The Expert Weighs In"
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. John Harris, founding director of the Vitiligo Clinic and Research Center, and the Autoimmune Therapeutics Institute at UMass Chan Medical School. Dr. Harris is also the founder of five companies -- proof you can be an academic and an entrepreneur at the same time. If you’re considerin … 
At-home skincare devices are now widely available to consumers, from handheld light wands for acne and wrinkles to laser hair removal devices. While no at-home device can fully mimic the benefits of in-office treatments, dermatologists spoke with Everyday Health and HuffPost about which at-home devices are worth consideration.
Dermatologist Dr. Rachel Westbay told HuffPost that consumers can us … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri … 
Intravenous immune globulin (IVIG) is a concentrate of pooled immunoglobulins derived from plasma donors. Its unique mechanism of action expands the utility of the medication to a variety of conditions. We continue our series, Therapeutic Cheat Sheet, with a closer look at IVIG, which is FDA-approved for the treatment of dermatologic conditions including dermatomyositis, Kawasaki disease, ITP, and …